BEAUMONT HOSPITAL’S Cancer Institute in Royal Oak, Mich., has begun construction of a proton therapy center. This will be the first single-room proton treatment center of its kind in Michigan.
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
